시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
캐리어 스크리닝 시장 규모, 점유율, 성장 분석 : 검사 유형별, 질환 유형별, 병상별, 기술별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Carrier Screening Market Size, Share, and Growth Analysis, By Test Type, By Disease Type, By Medical Condition, By Technology, By End User, By Region - Industry Forecast 2025-2032
상품코드 : 1670170
리서치사 : SkyQuest Technology Consulting Pvt. Ltd.
발행일 : 2025년 02월
페이지 정보 : 영문 177 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,395,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,651,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 9,907,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세계의 캐리어 스크리닝 시장 규모는 2023년에 25억 달러로 평가되며, 2024년 28억 3,000만 달러에서 2032년에는 76억 3,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 13.2%로 성장할 전망입니다.

유전성 질환의 발병률 증가와 예방적 헬스케어에 대한 관심이 높아짐에 따라 전 세계 보인자 선별검사 시장은 성장할 것으로 예상됩니다. 유전체 기술의 발전과 낭포성 섬유증, 테이삭스, 겸상 적혈구 빈혈과 같은 질병에 대한 인식이 높아짐에 따라 향후 수년간 보인자 선별 검사의 채택이 증가할 것으로 예상됩니다. 또한 유전자 검사에 대한 접근성이 개선되고, 유리한 상환 정책이 업계 관계자들에게 새로운 기회를 제공합니다. 그러나 표준화 부족, 신흥 시장에서의 낮은 인지도, 결과 해석의 복잡성, 고급 검사 기술에 따른 높은 비용 등의 문제는 2031년까지 시장 확대를 저해할 수 있습니다. 전반적으로 이 상황은 기술 혁신의 기회가 무르익은 상황이지만, 이해관계자들은 성장 기회를 활용하기 위해 이러한 장애물을 극복해야 합니다.

목차

서론

조사 방법

개요

시장 역학과 전망

주요 시장 인사이트

캐리어 스크리닝 시장 규모 : 검사 유형별

캐리어 스크리닝 시장 규모 : 질환 유형별

캐리어 스크리닝 시장 규모 : 병상별

캐리어 스크리닝 시장 규모 : 기술별

캐리어 스크리닝 시장 규모 : 최종사용자별

캐리어 스크리닝 시장 규모

경쟁 정보

주요 기업 개요

결론과 제안

KSA
영문 목차

영문목차

Global Carrier Screening Market size was valued at USD 2.5 billion in 2023 and is poised to grow from USD 2.83 billion in 2024 to USD 7.63 billion by 2032, growing at a CAGR of 13.2% during the forecast period (2025-2032).

The global carrier screening market is poised for growth, driven by the rising incidence of genetic diseases and an increasing focus on preventive healthcare. Advancements in genomic technologies and heightened awareness of disorders like cystic fibrosis, Tay-Sachs, and sickle cell anemia are expected to enhance the adoption of carrier screening in the coming years. Furthermore, improved accessibility to genetic testing and favorable reimbursement policies present new opportunities for industry players. However, challenges such as a lack of standardization, limited awareness in emerging markets, complexities in result interpretation, and the high costs associated with advanced testing technologies may hinder market progression through 2031. Overall, the landscape is ripe for innovation, but stakeholders must navigate these hurdles to capitalize on growth opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Carrier Screening market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Carrier Screening Market Segments Analysis

Global Carrier Screening Market is segmented by Test Type, Disease Type, Medical Condition, Technology, End User and region. Based on Test Type, the market is segmented into Molecular Screening Test and Biochemical Screening Test. Based on Disease Type, the market is segmented into Cystic Fibrosis, Tay-Sachs, Gaucher Disease, Sickle Cell Disease, Spinal Muscular Atrophy and Other Autosomal Recessive Genetic Disorders. Based on Medical Condition, the market is segmented into Pulmonary Conditions, Hematological Conditions, Neurological Conditions and Others. Based on Technology, the market is segmented into DNA Sequencing, Polymerase Chain Reaction, Microarrays and Others. Based on End User, the market is segmented into Hospitals, Reference Laboratories, Physician Offices and Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Carrier Screening Market

The growing prevalence of genetic disorders acts as a significant catalyst for the Global Carrier Screening market. As more individuals and families become aware of the risks associated with hereditary conditions, the demand for carrier screening tests rises. This heightened awareness drives healthcare providers to prioritize genetic screening as a preventive measure, allowing for informed decision-making and risk assessment. Furthermore, advancements in genetic testing technologies and increasing accessibility to these services contribute to the market's expansion. Ultimately, the high incidence of genetic disorders emphasizes the importance of carrier screening, fostering growth and innovation within the industry.

Restraints in the Global Carrier Screening Market

One of the significant challenges facing the global carrier screening market is the lack of standardization in screening panels. This issue can lead to inconsistencies in test results and interpretations, which may cause confusion among healthcare providers and patients alike. The variability in testing methodologies and panel compositions across different laboratories can hinder the reliability and comparability of results. Additionally, the absence of a unified framework may create barriers to widespread adoption of carrier screening, as stakeholders may be uncertain about the effectiveness and relevance of various screening options. Addressing this lack of standardization is crucial for the market's growth and acceptance.

Market Trends of the Global Carrier Screening Market

The Global Carrier Screening market is witnessing a significant trend towards the integration of digital health solutions, which is poised to enhance patient engagement and streamline the screening process. As companies increasingly adopt digital platforms, the convenience and accessibility of carrier screening services are expected to attract a broader demographic, ultimately driving market growth. This convergence fosters a more personalized healthcare experience, encouraging more individuals to participate in screening initiatives. By leveraging technology, companies can not only expand their operational reach but also refine their service offerings, positioning themselves favorably in a rapidly evolving healthcare landscape.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Carrier Screening Market Size by Test Type & CAGR (2025-2032)

Global Carrier Screening Market Size by Disease Type & CAGR (2025-2032)

Global Carrier Screening Market Size by Medical Condition & CAGR (2025-2032)

Global Carrier Screening Market Size by Technology & CAGR (2025-2032)

Global Carrier Screening Market Size by End User & CAGR (2025-2032)

Global Carrier Screening Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기